Antagonists of the system L neutral amino acid transporter (LAT) promote endothelial adhesivity of human red blood cells

Summary

The system L neutral amino acid transporter (LAT; LAT1, LAT2, LAT3, or LAT4) has multiple functions in human biology, including the cellular import of S-nitrosothiols (SNOs), biologically active derivatives of nitric oxide (NO). SNO formation by haemoglobin within red blood cells (RBC) has been studied, but the conduit whereby a SNO leaves the RBC remains unidentified. Here we hypothesised that SNO export by RBCs may also depend on LAT activity, and investigated the role of RBC LAT in modulating SNO-sensitive RBC-endothelial cell (EC) adhesion. We used multiple pharmacologic inhibitors of LAT in vitro and in vivo to test the role of LAT in SNO export from RBCs and in thereby modulating RBC-EC adhesion. Inhibition of human RBC LAT by type-1-specific or nonspecific LAT antagonists increased RBC-endothelial adhesivity in vitro, and LAT inhibitors tended to increase post-transfusion RBC sequestration in the lung and decreased oxygenation in vivo. A LAT1-specific inhibitor attenuated SNO export from RBCs, and we demonstrated LAT1 in RBC membranes and LAT1 mRNA in reticulocytes. The proadhesive effects of inhibiting LAT1 could be overcome by supplemental L-CSNO (S-nitroso-L-cysteine), but not D-CSNO or L-Cys, and suggest a basal anti-adhesive role for stereospecific intercellular SNO transport. This study reveals for the first time a novel role of LAT1 in the export of SNOs from RBCs to prevent their adhesion to ECs. The findings have implications for the mechanisms of intercellular SNO signalling, and for thrombosis, sickle cell disease, and post-storage RBC transfusion, when RBC adhesivity is increased.

Keywords

Transfusion - nitric oxide - S-nitrosothiol - erythrocyte - cysteine

^# These three authors contributed equally as co-first authors.

• References

• 1 Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655.
• 2 Serirom S, Raharjo WH, Chotivanich K. et al. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am J Pathol 2003; 162: 1651-1660.
• 3 Grossin N, Wautier MP, Wautier JL. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. Biorheology 2009; 46: 63-72.
• 4 Space SL, Lane PA, Pickett CK. et al. Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium. Am J Hematol 2000; 63: 200-204.
• 5 Riccio DA, Zhu H, Foster MW. et al. Renitrosylation of banked human red blood cells improves deformability and reduces adhesivity. Transfusion 2015; 55: 2452-2463.
• 6 Gutsaeva DR, Montero-Huerta P, Parkerson JB. et al. Molecular mechanisms underlying synergistic adhesion of sickle red blood cells by hypoxia and low nitric oxide bioavailability. Blood 2014; 123: 1917-1926.
• 7 Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature 2001; 409: 622-626.
• 8 Li S, Whorton AR. Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols. J Biol Chem 2005; 280: 20102-20110.
• 9 Li S, Whorton AR. Functional characterization of two S-nitroso-L-cysteine transporters, which mediate movement of NO equivalents into vascular cells. Am J Physiol Cell Physiol 2007; 292: C1263-C1271.
• 10 Morimoto E, Kanai Y, Kim DK. et al. Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters. J Pharmacol Sci 2008; 108: 505-516.
• 11 Verrey F, Closs EI, Wagner CA. et al. CATs and HATs: the SLC7 family of amino acid transporters. Pflug Arch Eur J Physiol 2004; 447: 532-542.
• 12 Christensen HN. Role of Amino Acid Transport and Countertransport in Nutrition and Metabolism. Physiol Rev 1990; 70: 43-77.
• 13 Granillo OM, Brahmajothi MV, Li S. et al. Pulmonary alveolar epithelial uptake of S-nitrosothiols is regulated by L-type amino acid transporter. Am J Physiol Lung Cell Mol Physiol 2008; 295: L38-L43.
• 14 Broniowska KA, Zhang Y, Hogg N. Requirement of transmembrane transport for S-nitrosocysteine-dependent modification of intracellular thiols. J Biol Chem 2006; 281: 33835-33841.
• 15 Zennadi R, Hines PC, De Castro LM. et al. Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions. Blood 2004; 104: 3774-3781.
• 16 Wempe MF, Rice PJ, Lightner JW. et al. Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound. Drug Metabol Pharmacokin 2012; 27: 155-161.
• 17 McMahon TJ, Stamler JS. Concerted nitric oxide/oxygen delivery by hemoglobin. Methods Enzymol 1999; 301: 99-114.
• 18 Zhu H, Zennadi R, Xu BX. et al. Impaired adenosine-5’-triphosphate release from red blood cells promotes their adhesion to endothelial cells: a mechanism of hypoxemia after transfusion. Crit Care Med 2011; 39: 2478-2486.
• 19 Oda K, Hosoda N, Endo H. et al. L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci 2010; 101: 173-179.
• 20 Bennett-Guerrero E, Veldman TH, Doctor A. et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007; 104: 17063-17068.
• 21 Hayashi K, Jutabha P, Kamai T. et al. LAT1 is a central transporter of essential amino acids in human umbilical vein endothelial cells. J Pharmacol Sci 2014; 124: 511-513.
• 22 Ritchie JW, Taylor PM. Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta. Biochem J 2001; 356: 719-725.
• 23 Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. J Am Med Assoc 1999; 282: 2035-2042.
• 24 Anniss AM, Sparrow RL. Variable adhesion of different red blood cell products to activated vascular endothelium under flow conditions. Am J Hematol 2007; 82: 439-445.
• 25 Wautier MP, Héron E, Picot J. et al. Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion. J Thromb Haemost 2011; 9: 1049-1055.
• 26 Wautier MP, El Nemer W, Gane P. et al. Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu/BCAM. Blood 2007; 110: 894-901.
• 27 van Bommel J, de Korte D, Lind A. et al. The effect of the transfusion of stored RBCs on intestinal microvascular oxygenation in the rat. Transfusion 2001; 41: 1515-1523.
• 28 Lipowsky HH, Sheikh NU, Katz DM. Intravital microscopy of capillary hemodynamics in sickle cell disease. J Clin Invest 1987; 80: 117-127.
• 29 Luk CS, Gray-Statchuk LA, Cepinkas G. et al. WBC reduction reduces storage-associated RBC adhesion to human vascular endothelial cells under conditions of continuous flow in vitro. Transfusion 2003; 43: 151-156.
• 30 Foster MW, McMahon TJ, Stamler JS. S-nitrosylation in health and disease. Trends Mol Med 2003; 9: 160-168.
• 31 Brahmajothi MV, Tinch BT, Wempe MF. et al. Hyperoxia inhibits nitric oxide treatment effects in alveolar epithelial cells via effects on L-type amino acid transporter-1. Antioxid Redox Signal 2014; 21: 1823-1836.
• 32 Koch C, Li L, Figueroa P. et al. Transfusion and pulmonary morbidity after cardiac surgery. Ann Thorac Surg 2009; 88: 1410-1418.
• 33 Koch CG, Li L, Sessler DI. et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-1239.
• 34 Hebert PC, Wells G, Blajchman MA. et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417.
• 35 Rotoli BM, Closs EI, Barilli A. et al. Arginine transport in human erythroid cells: discrimination of CAT1 and 4F2hc/y+LAT2 roles. Pflug Arch Eur J Physiol 2009; 458: 1163-1173.
• 36 Fox-Robichaud A, Payne D, Hasan SU. et al. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 1998; 101: 2497-2505.
• 37 Jia L, Bonaventura C, Bonaventura J. et al. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221-226.
• 38 Kallakunta VM, Slama-Schwok A, Mutus B. Protein disulfide isomerase may facilitate the efflux of nitrite derived S-nitrosothiols from red blood cells. Redox Biol 2013; 1: 373-380.
• 39 Takabe W, Kanai Y, Chairoungdua A. et al. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2. Arterioscl Thromb Vasc Biol 2004; 24: 1640-1645.
• 40 Matsuyama R, Tomi M, Akanuma S. et al. Upregulation of L-Type Amino Acid Transporter 1 (LAT1) in Cultured Rat Retinal Capillary Endothelial Cells in Response to Glucose Deprivation. Drug Metabol Pharmacokin 2012; 27: 317-324.
• 41 Campbell WA, Thompson NL. Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts. J Biol Chem 2001; 276: 16877-16884.
• 42 Kanai Y, Segawa H, Miyamoto K. et al. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998; 273: 23629-23632.
• 43 Rintoul RC, Buttery RC, Mackinnon AC. et al. Cross-linking CD98 promotes integrub-like signaling and anchorage-independent growth. Mol Biol Cell 2002; 13: 2841-2852.
• 44 Lacroix J, Hebert PC, Hutchison JS. et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356: 1609-1619.
• 45 Donadee C, Raat NJ, Kanias T. et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124: 465-476.
• 46 Reynolds JD, Bennett KM, Cina AJ. et al. S-nitrosylation therapy to improve oxygen delivery of banked blood. Proc Natl Acad Sci USA 2013; 110: 11529-11534.
• 47 Reynolds JD, Ahearn GS, Angelo M. et al. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci USA 2007; 104: 17058-17062.
• 48 Zhang R, Hess DT, Qian Z. et al. Hemoglobin betaCys93 is essential for cardiovascular function and integrated response to hypoxia. Proc Natl Acad Sci USA 2015; 112: 6425-6430.